Nonclinical Efficacy Testing » Non-Clinical CROs and Agencies » KAC Co., Ltd.

KAC Co., Ltd.

Table of Contents
Table of Contents

KAC is a contract research organization (CRO), that supports development of pharmaceutical/regenerative medical products. The company provides an end-to-end system, which covers the entire Non-clinical study process— supplying laboratory animals, conducting animal studies, performing evaluations, and analyzing results— entirely in-house.

Features of KAC Co., Ltd.’s Non-Clinical Study Services

Safety evaluation system for single and repeated dose toxicity studies

KAC offers a range of toxicity studies with a focus on single-dose and repeated-dose toxicity tests. The company also conducts local irritation studies (rabbit), sensitization testing, and other evaluations required for the non-clinical assessment of pharmaceuticals/regenerative medical products.

Flexible study designs with multiple animal species such as mice and rats are available. This enables a tailored proposal to each client's study needs.

Biological safety testing in accordance with ISO 10993

KAC conducts biological safety studies compliant with ISO 10993, including cytotoxicity and sensitization tests, supporting non-clinical evaluations for medical devices and regenerative medical products.

The company provides reliable safety data generated under test systems which are aligned with international standards. Examples include a variety of irritation assays and material reactivity assessments. Evaluation items can be customized according to the characteristics of client’s compound.

GLP-compliant testing system ensuring data reliability

KAC is a GLP(Good Laboratory Practice) compliant facility. They provide all of our non-clinical studies according to the GLP standard. The organization maintains appropriately managed facilities and operations to ensure the reliability and traceability of study data.

KAC is recognized as a research institution who continues their work to improve quality of each study.

Disease Models at KAC Co., Ltd.

CCI model (rat)

KAC supports studies using the rat Chronic Constriction Injury (CCI) model, one of the most widely used models for neuropathic pain. By applying mild constriction to peripheral nerves, changes in pain-related behaviors can be evaluated.

This model is commonly used for pharmacological efficacy studies, such as measuring responses to mechanical stimuli via the von Frey test. It enables the assessment of candidate therapeutics for neuropathic pain.

Reference:
https://www.kacnet.co.jp/service/bioscience/pain-test/pain-test.html

KAC Co., Ltd. Non-Clinical Study Case Examples

No case studies were available on the official website.

Company Information

Address40 Nishi Gekko-cho, Nishinokyo, Nakagyo-ku, Kyoto, Japan
Tel075-801-9311
Websitehttps://www.kacnet.co.jp/

3 Recommended Contract Research Organizations
for Non-Clinical Studies
— by Target goal and Expertise

In non-clinical development, the choice of contract research organization shapes the quality of the data and the time it takes to reach the next decision. Below, three CROs are introduced by the type of study they support: pharmacology (efficacy) studies, safety studies, and pharmacokinetic (PK/PD) studies. Each summary describes the services the company offers so that you can match a provider to your target and development objective.

Pharmacology (Efficacy) StudiesDisease-Relevant Models for
Translational Drug Evaluation
SMC Laboratories, Inc.
Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/)

SMC Laboratories, Inc.

SMC Laboratories is a specialized non-clinical CRO focused on in vivo pharmacology and efficacy studies using disease-relevant animal models, particularly in fibrosis, inflammation, metabolic diseases, and oncology.

Areas of Expertise
Disease-Relevant Model Portfolio

SMC Laboratories offers models covering the liver, lung, kidney, intestine, and oncology. Its portfolio includes the proprietary STAM™ model for MASH, fibrosis, and hepatocellular carcinoma.

Study Design Based on Target Biology

Study plans are developed around the target biology, mechanism of action, disease stage, and development objective. Pharmacological endpoints can be combined with histopathology, biomarkers, and disease-specific readouts.

Support from Target Validation to Proof of Concept

With experience from more than 1,000 studies for clients in 30 countries, SMC Laboratories supports programs from target validation and candidate selection through in vivo proof-of-concept studies.

Safety StudiesComprehensive Safety Assessment for
Preclinical Development
Charles River Laboratories
Reference: Charles River Laboratories official website (https://www.criver.com/)

Charles River Laboratories

Charles River provides non-clinical toxicology and safety assessment services for programs ranging from exploratory safety studies to IND-enabling development.

Areas of Expertise
General Toxicology Across Study Designs

Services include single- and repeat-dose toxicology, dose-range finding, and general toxicology studies across multiple species and administration routes.

Non-GLP and GLP Study Support

Charles River supports both non-GLP and GLP studies, allowing sponsors to progress from early safety characterization to studies intended for regulatory submissions.

Integrated IND-Enabling Safety Assessment

Toxicology studies can be integrated with toxicokinetics, clinical pathology, histopathology, and safety pharmacology to support interpretation and IND-enabling safety packages.

Pharmacokinetic (PK/PD) StudiesConnecting Drug Exposure with
Pharmacological Response
Inotiv
Reference: Inotiv official website (https://www.inotiv.com/)

Inotiv

Inotiv provides integrated PK/PD, DMPK, and bioanalytical services to characterize drug exposure and its relationship with pharmacological response.

Areas of Expertise
Pharmacokinetic Characterization

PK studies characterize exposure, half-life, clearance, and other pharmacokinetic parameters needed to understand how a candidate behaves in the selected model.

Exposure–Response Evaluation

Pharmacokinetic data can be combined with pharmacodynamic endpoints and bioanalysis to evaluate the relationship between drug exposure and pharmacological response.

Integrated DMPK and Development Support

Integrated DMPK, pharmacology, and safety information supports candidate comparison, dose selection, dosing-frequency optimization, and decisions about subsequent preclinical development.

By Therapeutic Area
Disease Animal Models
and Reviews
Proven Capability, Expertise and Track Record
Top 3 Non-Clinical CRO Services